Author:
Yang Zhenlin,Han Shuo,Keller Max,Kaiser Anette,Bender Brian J.,Bosse Mathias,Burkert Kerstin,Kögler Lisa M.,Wifling David,Bernhardt Guenther,Plank Nicole,Littmann Timo,Schmidt Peter,Yi Cuiying,Li Beibei,Ye Sheng,Zhang Rongguang,Xu Bo,Larhammar Dan,Stevens Raymond C.,Huster Daniel,Meiler Jens,Zhao Qiang,Beck-Sickinger Annette G.,Buschauer Armin,Wu Beili
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Zhang, L., Bijker, M. S. & Herzog, H. The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer. Pharmacol. Ther. 131, 91–113 (2011).
2. Morales-Medina, J. C., Dumont, Y. & Quirion, R. A possible role of neuropeptide Y in depression and stress. Brain Res. 1314, 194–205 (2010).
3. Michel, M. C. et al. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50, 143–150 (1998).
4. Yulyaningsih, E., Zhang, L., Herzog, H. & Sainsbury, A. NPY receptors as potential targets for anti-obesity drug development. Br. J. Pharmacol. 163, 1170–1202 (2011).
5. Sousa, D. M., Herzog, H. & Lamghari, M. NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target. Curr. Drug Targets 10, 9–19 (2009).
Cited by
106 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献